Drug Approval | January 08, 2026
Briefs: Medicamen Biotech and Gland Pharma
Gland Pharma receives approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC)
Gland Pharma receives approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC)
Kelun-Biotech and Crescent Biopharma forged a collaboration covering SKB105/CR-003 and SKB118, a PD-1 x VEGF bispecific antibody also known as CR-001
GlideTech materials are available in several standard base resins and offer customization options for specific applications
Sovaaka offers a deeply personalised diagnostics-led wellness experience that goes beyond routine health checks
Leaders from science, policy, industry, and investment came together in New Delhi to examine how alignment across the biotechnology value chain can turn innovation into outcomes at scale
Syrma Johari is a globally recognised medical device engineering and manufacturing organisation
BBIL will guarantee production and supply of MTBVAC to more than 70 countries across Africa and Southeast Asia
The trial will evaluate the efficacy and safety of IPX203 versus immediate-release levodopa/carbidopa
Under the agreement, AVT06 is licensed to enter the US market in the fourth quarter of 2026
The announcement came during the inauguration of the college’s Innovation & Incubation Centre and Health Club
Subscribe To Our Newsletter & Stay Updated
